首页> 外文期刊>Cytogenetic and genome research >Array-Comparative Genomic Hybridization Analysis in Fetuses with Major Congenital Malformations Reveals that 24% of Cases Have Pathogenic Deletions/Duplications
【24h】

Array-Comparative Genomic Hybridization Analysis in Fetuses with Major Congenital Malformations Reveals that 24% of Cases Have Pathogenic Deletions/Duplications

机译:具有主要先天性畸形的胎儿的阵列比较基因组杂交分析显示,有24%的病例具有病原性缺失/重复

获取原文
获取原文并翻译 | 示例
       

摘要

Karyotyping and aCGH are routinely used to identify genetic determinants of major congenital malformations (MCMs) in fetal deaths or terminations of pregnancy after prenatal diagnosis. Pathogenic rearrangements are found with a variable rate of 9-39% for aCGH. We collected 33 fetuses, 9 with a single MCM and 24 with MCMs involving 2-4 organ systems. aCGH revealed copy number variants in 14 out of 33 cases (42%). Eight were classified as pathogenic which account for a detection rate of 24% (8/33) considering fetuses with 1 or more MCMs and 33% (8/24) taking into account fetuses with multiple malformations only. Three of the pathogenic variants were known microdeletion syndromes (22q11.21 deletion, central chromosome 22q11.21 deletion, and TAR syndrome) and 5 were large rearrangements, adding up to >11 Mb per subject and comprising strong phenotype-related genes. One of those was a de novo complex rearrangement, and the remaining 4 duplications and 2 deletions were 130-900 kb in size, containing 1-7 genes, and were classified as variants of unknown clinical significance. Our study confirms aCGH as a powerful technique to ascertain the genetic etiology of fetal major congenital malformations. (C) 2015 S. Karger AG, Basel
机译:染色体核型分析和aCGH通常用于鉴定产前诊断后胎儿死亡或终止妊娠的主要先天性畸形(MCM)的遗传决定因素。发现aCGH的致病性重排可变率为9-39%。我们收集了33例胎儿,其中9例为单个MCM,24例为MCM,涉及2-4个器官系统。 aCGH在33例病例中有14例显示了拷贝数变异(42%)。考虑到具有1个或多个MCM的胎儿,有8个被分类为致病性,占24%(8/33)的检出率,仅考虑具有多个畸形的胎儿,占33%(8/24)的检出率。其中三个致病变异是已知的微缺失综合症(22q11.21缺失,中央染色体22q11.21缺失和TAR综合征),其中5个是大的重排,每个受试者加起来> 11 Mb,并包含与表型相关的强基因。其中之一是从头复合物重排,其余4个重复和2个缺失大小为130-900 kb,包含1-7个基因,被归类为临床意义未知的变体。我们的研究证实aCGH是确定胎儿主要先天畸形的遗传病因的有力技术。 (C)2015 S.Karger AG,巴塞尔

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号